{"product_id":"cjc-1295-no-dac","title":"CJC-1295 No DAC 10mg","description":"\u003cp\u003eCJC-1295 no DAC is a modified GHRH analog used in research on pulsatile growth hormone release and pituitary signaling.\u003c\/p\u003e\n\u003cp\u003eCJC-1295 without DAC is a tetrasubstituted GHRH analog designed for enhanced receptor affinity and predictable pulsatile GH release. Unlike the DAC version, this form has a shorter half-life and is therefore used in models that require dynamic GH pulse frequency rather than sustained elevation. Researchers frequently explore its impact on IGF-1 regulation, pituitary responsiveness, and hypothalamic-pituitary communication.\u003c\/p\u003e\n\u003cdiv data-widget_type=\"heading.default\" data-e-type=\"widget\" data-element_type=\"widget\" data-id=\"70108bd\" class=\"elementor-element elementor-element-70108bd elementor-widget elementor-widget-heading\"\u003e\n\u003ch3 class=\"elementor-heading-title elementor-size-default\"\u003ePen Dosage Chart\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv data-widget_type=\"text-editor.default\" data-e-type=\"widget\" data-element_type=\"widget\" data-id=\"a2c1f5a\" class=\"elementor-element elementor-element-a2c1f5a color-scheme-inherit text-left elementor-widget elementor-widget-text-editor\"\u003e\n\u003ctable style=\"width: 100%;\" cellpadding=\"10\" cellspacing=\"0\" border=\"1\"\u003e\n\u003ccolgroup\u003e \u003ccol style=\"width: 21.033868%;\" width=\"50%\"\u003e \u003ccol style=\"width: 78.787879%;\" width=\"50%\"\u003e \u003c\/colgroup\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eCJC-1295 No DAC 10mg QuickPen Pro\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVolume\u003c\/td\u003e\n\u003ctd\u003e3.0 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003emg\/mL\u003c\/td\u003e\n\u003ctd\u003e3.33 mg\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClick-to-Dose\u003c\/td\u003e\n\u003ctd\u003e1 click = 0.033 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExample(s)\u003c\/td\u003e\n\u003ctd\u003e30 clicks(10 of Pen Scale) = 1 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003cp data-end=\"839\" data-start=\"425\"\u003e \u003c\/p\u003e\n\u003cdiv data-widget_type=\"heading.default\" data-e-type=\"widget\" data-element_type=\"widget\" data-id=\"3839bb6\" class=\"elementor-element elementor-element-3839bb6 elementor-widget elementor-widget-heading\"\u003e\n\u003ch3 class=\"elementor-heading-title elementor-size-default\"\u003eBenefits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv data-widget_type=\"text-editor.default\" data-e-type=\"widget\" data-element_type=\"widget\" data-id=\"a88a59d\" class=\"elementor-element elementor-element-a88a59d color-scheme-inherit text-left elementor-widget elementor-widget-text-editor\"\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eEnhances natural pulsatile growth hormone secretion:\u003c\/b\u003e\u003cbr\u003eCJC-1295 (No DAC) amplifies endogenous growth hormone release by directly stimulating the GHRH receptor pathway in the anterior pituitary. Growth hormone is physiologically secreted in discrete pulses, with peak amplitude occurring during deep sleep phases. Rather than producing continuous elevation, CJC-1295 increases the magnitude of these pulses while preserving their rhythmic nature. This pulsatile enhancement is central to maintaining receptor sensitivity and preventing desensitization associated with sustained hormone exposure. The short-acting profile allows GH levels to rise and fall within natural regulatory parameters.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSelective engagement of the GHRH receptor cascade:\u003c\/b\u003e\u003cbr\u003eCJC-1295 (No DAC) binds specifically to the growth hormone–releasing hormone receptor (GHRH-R), a G-protein–coupled receptor expressed on somatotroph cells. Activation of this receptor increases adenylate cyclase activity, elevating intracellular cAMP levels. This rise in cAMP activates protein kinase A, leading to enhanced transcription and exocytosis of growth hormone. Unlike ghrelin-based peptides that act through the GHS-R1a receptor, CJC-1295 does not directly stimulate appetite-related hypothalamic pathways. This receptor specificity differentiates it mechanistically from GHRP compounds.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePreserves hypothalamic somatostatin regulation:\u003c\/b\u003e\u003cbr\u003eThe hypothalamus tightly controls GH release through a balance between GHRH stimulation and somatostatin inhibition. Because CJC-1295 stimulates endogenous pathways rather than bypassing them, somatostatin feedback remains active. This allows the body to modulate hormone output dynamically based on physiologic demand. Maintaining this inhibitory counterbalance is important in experimental models examining long-term endocrine stability.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSupports downstream IGF-1–mediated anabolic signaling:\u003c\/b\u003e\u003cbr\u003eOnce growth hormone is released, it stimulates hepatic production of insulin-like growth factor 1 (IGF-1). IGF-1 activates intracellular pathways including PI3K\/Akt and mTOR, which regulate protein synthesis and cellular growth. Through this two-step endocrine cascade, CJC-1295 indirectly influences tissue adaptation and recovery-related signaling. This layered activation preserves physiological hierarchy rather than directly activating peripheral receptors.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eShort-acting profile enables pulse timing studies:\u003c\/b\u003e\u003cbr\u003eUnlike the DAC-modified formulation, the No DAC version lacks albumin-binding extension and therefore has a shorter half-life. This transient activity allows researchers to evaluate timing-dependent endocrine responses and synchronization with circadian cycles. Pulse timing plays a critical role in how tissues respond to growth hormone exposure. By aligning with physiologic rhythms, CJC-1295 (No DAC) supports research focused on hormone pattern optimization rather than continuous stimulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eInfluences sleep-associated growth hormone peaks:\u003c\/b\u003e\u003cbr\u003eGrowth hormone secretion is closely linked to slow-wave sleep. Amplifying physiologic GH pulses may enhance the magnitude of nocturnal hormone peaks in experimental models. This connection places CJC-1295 within integrated sleep–endocrine research frameworks. Rather than inducing sleep directly, it operates within hormonal cycles that coincide with restorative phases.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eDistinct from ghrelin mimetics and appetite-driven peptides:\u003c\/b\u003e\u003cbr\u003eGHRP compounds stimulate growth hormone release via ghrelin receptor activation and may influence hunger pathways. CJC-1295 operates exclusively through the GHRH receptor pathway, avoiding direct activation of neuropeptide Y–mediated appetite signaling. This distinction makes it more focused on pituitary modulation than hypothalamic hunger circuits. The absence of strong appetite stimulation differentiates its systemic profile.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFacilitates structured endocrine modulation research:\u003c\/b\u003e\u003cbr\u003eBecause it enhances natural hormone pulses rather than replacing GH, CJC-1295 supports investigation into physiologic endocrine adaptation. The preservation of feedback loops, receptor sensitivity, and pulse rhythm allows researchers to examine nuanced hormonal modulation. This precision positions the No DAC variant within rhythm-aligned growth hormone research rather than sustained supraphysiologic exposure models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIntegrates within broader neuroendocrine coordination networks:\u003c\/b\u003e\u003cbr\u003eGrowth hormone interacts with metabolic regulation, connective tissue remodeling, and circadian timing systems. By amplifying endogenous GH pulses, CJC-1295 participates in this integrated neuroendocrine network. Its activity reflects coordinated communication between hypothalamus, pituitary, and peripheral tissues. This systems-level positioning differentiates it from peptides that act directly at peripheral receptors without upstream regulatory integration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"Quickpen Pro Peptides","offers":[{"title":"Default Title","offer_id":57221836505465,"sku":null,"price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0999\/0776\/4601\/files\/cjc-1295-no-dac-10mg-9483367.png?v=1778161513","url":"https:\/\/www.quickpen.pro\/products\/cjc-1295-no-dac","provider":"Quickpen Pro Peptides","version":"1.0","type":"link"}